| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 2024 | RXST Rxsight, Inc. | Goldshleger Ilya81 | See Remarks | Sell | 9,305 | $49.70 | $462,457.53 | -6.8% | -38.9% | -84.6% | |
| Oct 11, 2024 | NEOG Neogen Corp | Adent John Edward49 | CEO | Buy | 14,500 | $13.80 | $200,100.00 | +7.2% | -14.3% | -58.1% | |
| Oct 11, 2024 | RMD Resmed Inc | Ghoshal Kaushik64 | Chief Commercial Officer, Saas | Sell | 4,260 | $238.48 | $1,015,924.80 | -16.4% | -2.8% | +13.1% | |
| Oct 10, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 6,234 | $0.74 | $4,632.49 | - | -0.4% | +29.1% | |
| Oct 10, 2024 | ANGO Angiodynamics Inc | Nighan Warren Jr74 | SVP Quality And Regulatory | Buy | 868 | $6.09 | $5,285.12 | +1.0% | +110.7% | +79.2% | |
| Oct 8, 2024 | STIM Neuronetics, Inc. | Furlong Stephen74 | EVP, CFO And Treasurer | Sell | 1,368 | $0.82 | $1,121.76 | -0.3% | +82.6% | +245.3% | |
| Oct 8, 2024 | RMD Resmed Inc | Sandercock Brett62 | Chief Financial Officer | Sell | 1,000 | $233.47 | $233,470.00 | -1.0% | -0.4% | +19.6% | |
| Oct 8, 2024 | ANGO Angiodynamics Inc | Trowbridge Stephen A | EVP And CFO | Buy | 1,700 | $5.86 | $9,962.00 | +1.0% | +57.7% | +89.1% | |
| Oct 8, 2024 | STIM Neuronetics, Inc. | MacAn William Andrew66 | EVP, GC, CCO And Cs | Sell | 1,541 | $0.82 | $1,263.62 | -0.4% | +82.6% | +245.3% | |
| Oct 8, 2024 | RXST Rxsight, Inc. | Goldshleger Ilya81 | See Remarks | Sell | 6,200 | $48.13 | $298,436.60 | -3.5% | -28.1% | -83.3% | |
| Oct 7, 2024 | BSX Boston Scientific Corp | Fitzgerald Joseph Michael51 | EVP &Group Pres, Cardiology | Sell | 132,527 | $85.00 | $11,264,887.77 | -45.2% | +8.2% | +13.6% | |
| Oct 7, 2024 | RMD Resmed Inc | Farrell Michael J.63 | Chief Executive Officer | Sell | 14,683 | $231.91 | $3,405,206.48 | -3.1% | +1.2% | +22.0% | |
| Oct 7, 2024 | ANGO Angiodynamics Inc | Clemmer James C50 | President And CEO | Buy | 20,000 | $6.03 | $120,600.00 | +3.0% | +52.0% | +81.1% | |
| Oct 7, 2024 | SERA Sera Prognostics, Inc. | Mirza Mansoor Raza79 | Director | Sell | 96 | $7.15 | $686.40 | -1.4% | +11.3% | -53.0% | |
| Oct 7, 2024 | BSX Boston Scientific Corp | Mahoney Michael F57 | Chairman, President &CEO | Sell | 162,777 | $84.63 | $13,775,791.62 | -4.8% | +8.2% | +13.6% | |
| Oct 5, 2024 | TLSI Trisalus Life Sciences, Inc. | Cox Bryan F. | Chief Scientific &Manufact. | Sell | 314 | $4.44 | $1,394.16 | -0.4% | +10.3% | +1.8% | |
| Oct 3, 2024 | VERO Venus Concept Inc. | Masters Michael Willingham83 | 10% Owner | Sell | 162,896 | $0.53 | $85,552.98 | -21.9% | -21.2% | -58.2% | |
| Oct 3, 2024 | SIBN Si-Bone, Inc. | Recupero Anthony J63 | President, Commercial Ops | Sell | 4,226 | $13.58 | $57,402.83 | -0.6% | +0.6% | +4.7% | |
| Oct 2, 2024 | SIBN Si-Bone, Inc. | Maheshwari Anshul67 | Chief Financial Officer | Sell | 3,305 | $13.58 | $44,886.32 | -0.8% | +3.1% | +5.2% | |
| Oct 2, 2024 | SGHT Sight Sciences, Inc. | Badawi David59 | Chief Technology Officer | Sell | 3,167 | $5.99 | $18,957.66 | -0.2% | -41.1% | -46.4% | |
| Oct 2, 2024 | SGHT Sight Sciences, Inc. | Badawi Paul62 | President And CEO | Sell | 12,727 | $5.99 | $76,183.82 | -0.2% | -41.1% | -46.4% | |
| Oct 2, 2024 | PEN Penumbra Inc | Grewal Harpreet60 | Director | Sell | 166 | $190.83 | $31,677.78 | -1.9% | +23.0% | +31.3% | |
| Oct 2, 2024 | RMD Resmed Inc | Farrell Peter C55 | Director | Sell | 2,000 | $237.20 | $474,400.00 | -2.3% | -4.3% | +15.8% | |
| Oct 2, 2024 | MXCT Maxcyte, Inc. | Erck Stanley C86 | Director | Sell | 47,689 | $3.75 | $178,751.93 | -8.1% | +11.2% | -57.0% | |
| Oct 2, 2024 | VERO Venus Concept Inc. | Masters Michael Willingham83 | 10% Owner | Sell | 306,135 | $0.59 | $179,640.96 | -10.7% | -26.2% | -56.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.